Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
China · Delayed Price · Currency is CNY 12.28
+0.26 (2.16%)
Jul 31, 2026, 3:00 PM CST
SHA:688658 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,425 | 2,446 | 3,781 | 4,196 | 4,542 | 4,966 |
Revenue Growth | -28.48% | -35.30% | -9.90% | -7.61% | -8.53% | 14.45% |
Gross Profit Gross Profit Growth | 1,246 | 1,188 | 2,141 | 2,574 | 2,873 | 3,410 |
Operating Income Operating Income Growth | -211.59 | -235.77 | 213.69 | 214.88 | 240 | 574.2 |
Net Income Net Income Growth | -246.22 | -262.39 | 123.72 | 184.8 | 335.18 | 545.32 |
Earnings Per Share EPS Growth | -0.55 | -0.59 | 0.28 | 0.41 | 0.74 | 1.21 |
EPS Growth | - | - | -31.71% | -44.59% | -38.84% | -1.63% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Anti-Infective Anti-Infective Growth | 589.49 |
Cardiovascular Cardiovascular Growth | 1,062 |
Digestive System Digestive System Growth | 209.84 |
Hypoglycemic Hypoglycemic Growth | 179.68 |
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth | 212.15 |
Technical Services Technical Services Growth | 2.09 |
Other Other Growth | 184.53 |
Total Total Growth | 2,440 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,372 | 1,420 | 1,493 | 1,483 | 1,661 | 2,437 |
Total Debt Total Debt Growth | 614.78 | 608.15 | 705.31 | 462.91 | 277.75 | 37.55 |
Net Cash (Debt) Net Cash Growth | 757.18 | 811.7 | 787.86 | 1,020 | 1,384 | 2,400 |
Net Cash Growth | -5.55% | 3.03% | -22.73% | -26.31% | -42.34% | 2.81% |
Net Cash Per Share Net Cash Per Share Growth | 1.68 | 1.83 | 1.78 | 2.26 | 3.05 | 5.32 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 303.72 | 340.29 | 438.24 | 785.49 | -121.17 | 515.24 |
Capital Expenditures CapEx Growth | -103.54 | -135.08 | -358.6 | -497.48 | -547.96 | -200.49 |
Free Cash Flow Free Cash Flow Growth | 200.18 | 205.21 | 79.64 | 288.01 | -669.13 | 314.75 |
Free Cash Flow Growth | 318.75% | 157.67% | -72.35% | - | - | -44.87% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.40% | 48.58% | 56.62% | 61.35% | 63.25% | 68.67% |
Operating Margin | -8.73% | -9.64% | 5.65% | 5.12% | 5.28% | 11.56% |
Pretax Margin | -8.60% | -9.69% | 4.03% | 5.32% | 7.70% | 12.67% |
Profit Margin | -10.15% | -10.73% | 3.27% | 4.40% | 7.38% | 10.98% |
FCF Margin | 8.26% | 8.39% | 2.11% | 6.86% | -14.73% | 6.34% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 1.100 | 0.680 |
Dividend Per Share Growth | -81.82% | 61.77% | 51.11% |
Dividend Yield | 0.97% | 5.99% | 2.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 51.77 | 50.80 | 25.94 | 24.52 |
Forward PE | - | 161.50 | 17.00 | - | - | - |
P/FCF Ratio | 27.27 | 48.97 | 80.43 | 32.59 | - | 42.48 |
PS Ratio | 2.25 | 4.11 | 1.69 | 2.24 | 1.91 | 2.69 |